SCHEMBL308213

SCHEMBL308213

CCn1cncc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21558238 0.79 ALDH1A1 (0.40) —
SCHEMBL15201855 0.76 CYP17A1 (0.33) —
SCHEMBL21558234 0.76 POLB (0.37) —
SCHEMBL2308094 0.73 — —
SCHEMBL22833830 0.73 — —
SCHEMBL25415828 0.73 MEN1 (0.40) —
SCHEMBL21341552 0.71 — —
SCHEMBL1396049 0.71 — —
SCHEMBL30553456 0.71 — —
SCHEMBL2379424 0.70 KCNH2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024217500-A1 ISOQUINOLINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 上海赛默罗生物科技有限公司 2024-10-24 — — WO disclosed
CN-118359538-A Isoquinoline compound, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2024-07-19 — — CN disclosed
EP-2814814-B1 IMIDAZOLYLKETONE DERIVATIVES ASD ALDOSTERONE SYNTHASE INHIBITORS HOFFMANN LA ROCHE (CH) 2019-05-08 — — EP disclosed
EP-2814814-B1 IMIDAZOLYLKETONE DERIVATIVES ASD ALDOSTERONE SYNTHASE INHIBITORS HOFFMANN LA ROCHE (CH) 2019-05-08 — — EP disclosed
EP-1957498-B1 INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING METHYLGENE INC (CA) 2017-02-15 — — EP disclosed
US-9464058-B2 Imidazolylketone derivatives HOFFMANN-LA ROCHE INC. (US) 2016-10-11 — — US disclosed
US-9464058-B2 Imidazolylketone derivatives HOFFMANN-LA ROCHE INC. (US) 2016-10-11 — — US disclosed
US-9464058-B2 Imidazolylketone derivatives HOFFMANN-LA ROCHE INC. (US) 2016-10-11 — — US disclosed
EP-2814814-A1 IMIDAZOLYLKETONE DERIVATIVES ASD ALDOSTERONE SYNTHASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-12-24 — — EP disclosed
US-20140128429-A1 NEW IMIDAZOLYLKETONE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2014-05-08 — — US disclosed
US-8329726-B2 Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE INC. (CA) 2012-12-11 — — US disclosed
US-20120083482-A1 INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING METHYLGENE INC. 2012-04-05 — — US disclosed
US-20120083482-A1 INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING METHYLGENE INC. 2012-04-05 — — US disclosed
US-8093264-B2 Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE INC. (CA) 2012-01-10 — — US disclosed
US-8093264-B2 Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE INC. (CA) 2012-01-10 — — US disclosed
US-8093264-B2 Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE INC. (CA) 2012-01-10 — — US disclosed
CN-101796055-A Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE INC 2010-08-04 — — CN disclosed
US-20070004675-A1 Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE, INC. 2007-01-04 — — US disclosed
US-20070004675-A1 Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE, INC. 2007-01-04 — — US disclosed
US-20070004675-A1 Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE, INC. 2007-01-04 — — US disclosed
Send feedback